
|
|
|
|
|
|
|
North American Branch of the International Life Sciences Institute 1156 15th Street, NW Suite 200 Washington, DC 20005
P: 202.659.0074 F: 202.659.3859 E: ilsina@ilsi.org
Staff listing click here. |
|
|
|
|
|
|
The International Life Sciences Institute (ILSI) is a nonprofit, worldwide organization whose mission is to improve public health and well-being. It achieves this mission by engaging academic, government, and industry experts in a neutral forum to advance scientific understanding related to nutrition, food safety, risk assessment, and the environment.
ILSI North America is a neutral forum and most recognized source for identifying important key scientific emerging issues and disseminating sound science based information for the benefit of the scientific community and general public. The scientific areas of focus include food science, nutrition, safety, and risk assessment which are investigated through technical committees of expert scientists representing all sectors of academia, government, and industry. As a research catalyst, ILSI North America’s leading expert scientists contribute new information to fill current knowledge gaps by means of publications, symposia, partnerships with specialized scientific societies, and providing scientific data to governmental organizations when appropriate. Additional information (click here).
To access the 2009 ILSI North America Annual Report (click here).
Scientific Presentations from the 2010 ILSI North America Annual Meeting are now available (click here). |
|

|
|
|
|
|
|
Obesity 2010 Annual MeetingSan Diego, CA, 10/8/2010 - 10/12/2010 Read More |
IOM Food Forum Workshop - Leveraging Food Technology for Obesity Prevention and Reduction EffortsWashington, DC, 11/2/2010 - 11/3/2010 Read More |
ADA Food Nutrition Conference & ExpoBoston, MA, 11/6/2010 - 11/9/2010 Read More |
|
|
|
A Method to Assess the Quality of Studies That Examine the Toxicity of Engineered NanomaterialsJournal Article, 2010 As reports on the safety of various nanomaterials have yielded conflicting results, assessment of the reliability of each study is required to objectively interpret overall safety of the nanomaterial. A 2-step method to assess the quality of nanotoxicity studies is described. The first step uses a publicly available tool to rank the reliability of the study based on adequacy of design and documentation of methods, materials, and results, providing a ‘‘study score.’’ The second step determines the completeness of physicochemical characterization of the nanomaterial/nanomaterials assessed within the study, providing a ‘‘nanomaterial score.’’ This approach is encouraged to promote the notion that for studies conducted with nanomaterials, the combination of a reliable study and sufficient nanomaterial characterization is of significantly greater value than either of these alone. It is anticipated that the use and evolution of this approach will assist with the design and interpretation of studies assessing nanomaterial toxicity. Read More |
A Review of the Epidemiologic Evidence Concerning the Reproductive Health Effects of Caffeine Consumption: A 2000–2009 UpdateJournal Article, 2010
This review of human studies of caffeine and reproductive health published between January 2000 and December 2009 serves to update the comprehensive review published by Leviton and Cowan (2002). The adverse reproductive outcomes addressed in this review include: (1) measures of subfecundity; (2) spontaneous abortion; (3) fetal death; (4) preterm birth; (5) congenital malformations; and (6) fetal growth restriction. Methodologic challenges and considerations relevant to investigations of each reproductive endpoint are summarized, followed by a brief critical review of each study. The evidence for an effect of caffeine on reproductive health and fetal development is limited by the inability to rule out plausible alternative explanations for the observed associations, namely confounding by pregnancy symptoms and smoking, and by exposure measurement error. Because of these limitations, the weight of evidence does not support a positive relationship between caffeine consumption and adverse reproductive or perinatal outcomes. Read More |
Comparison of Virulence of Three Strains of Cronobacter sakazakii in Neonatal CD-1 MiceJournal Article, 2010
The study objective was to compare the virulence of three strains of C. sakazakii in neonatal CD-1 mice. Our findings suggest that invasiveness does not necessarily correlate with mortality among different strains of C. sakazakii, and the clinical isolates are more virulent than the food isolate. Read More |
Funding Food Science and Nutrition Research: Financial Conflicts and Scientific IntegrityJournal Article, 2009
This paper discusses conflict-of-interest guidelines regarding industry funding to protect the integrity and credibility of the scientific record, particularly with respect to health, nutrition, and food-safety science. Eight principles are enumerated, which specify the ground rules for industry-sponsored research. Read More |
Intake of Added Sugars and Selected Nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003—2006Journal Article, 2010
The primary objectives of this study were to utilize National Health and Nutrition Examination Survey (NHANES) to update the reference table data on intake of added sugars from the IOM report and compute food sources of added sugars. Read More |
Persistence of Human Noroviruses on Food Preparation Surfaces and Human HandsJournal Article, 2010
The human noroviruses (NoV) are the major cause of acute non-bacterial gastroenteritis and are commonly transmitted by foodborne routes. Epidemiological evidence from propagated outbreaks, as well as environmental sampling, suggest that these viruses are environmentally stable. The purpose of this study was to examine the persistence of representative human NoV on the fingertips of volunteers and on commonly used food preparation surfaces. Read More |
Selection and Characterization of DNA Aptamers with Binding Selectivity to Campylobacter jejuni using Whole-Cell SELEXJournal Article, 2010
The need for pre-analytical sample processing prior to the application of rapid molecular-based detection of pathogens in food and environmental samples is well established. Although immunocapture has been applied in this regard, alternative ligands such as nucleic acid aptamers have advantages over antibodies such as low cost, ease of production and modification, and comparable stability. To identify DNA aptamers demonstrating binding specificity to Campylobacter jejuni cells, a whole-cell Systemic Evolution of Ligands by EXponential enrichment (SELEX) method was applied to a combinatorial library of FAM-labeled single-stranded DNA molecules. FAM-labeled aptamer sequences with high binding affinity to C. jejuni A9a as determined by flow cytometric analysis were identified. Aptamer ONS-23, which showed particularly high binding affinity in preliminary studies, was chosen for further characterization. This aptamer displayed a dissociation constant (K d value) of 292.8 ± 53.1 nM with 47.27 ± 5.58% cells fluorescent (bound) in a 1.48-μM aptamer solution. Binding assays to assess the specificity of aptamer ONS-23 showed high binding affinity (25–36%) for all other C. jejuni strains screened (inclusivity) and low apparent binding affinity (1–5%) with non-C. jejuni strains (exclusivity). Whole-cell SELEX is a promising technique to design aptamer-based molecular probes for microbial pathogens without tedious isolation and purification of complex markers or targets. Read More |
The Tricks Learnt by Human Enteric Pathogens from Phytopathogens to Persist within the Plant Environment.Journal Article, 2010
Through recent advances in our understanding of microbial:plant interactions it is becoming apparent that human pathogens, principally, Escherichia coli O157:H7 and Salmonella are adapted to survive in the plant environment. The aforementioned pathogens have surface epitopes that can bind to plant structures such as stomata to aid attachment. Read More |
Threshold Dose for Peanut: Risk Characterization Based upon Diagnostic Oral Challenge of a Series of 286 Peanut-allergic IndividualsJournal Article, 2010
Clinical records of 286 consecutive patients reacting positively with objective symptoms to double-blind, placebo-controlled oral peanut challenges at University Hospital, Nancy, France were examined for individual No Observed Adverse Effect Levels (NOAELs) and Lowest Observed Adverse Effect Levels (LOAELs). Read More |
|
|
|
|
|
|